RCM
SLXNW

Rivernorth Capital Management’s Silexion Therapeutics Corp Warrant SLXNW Stock Holding History

Rivernorth Capital Management’s Portfolio SLXNW Stock Details SLXNW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-14,999
Closed -$1.15K – 385
2025
Q1 		$1.15K Hold
14,999
– – ﹤0.01% 344
2024
Q4 		$508 Hold
14,999
– – ﹤0.01% 401
2024
Q3 		$472 Buy
+14,999
New +$472 ﹤0.01% 375